摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,17,20-Trihydroxypregnane | 33995-20-9

中文名称
——
中文别名
——
英文名称
3,17,20-Trihydroxypregnane
英文别名
(8R,9S,10S,13S,14S,17R)-17-(1-hydroxyethyl)-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
3,17,20-Trihydroxypregnane化学式
CAS
33995-20-9
化学式
C21H36O3
mdl
——
分子量
336.5
InChiKey
SCPADBBISMMJAW-JDIROBOTSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    24
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    60.7
  • 氢给体数:
    3
  • 氢受体数:
    3

文献信息

  • Cholesterol-lowering agents, secondary bile acid production inhibitors and foods and drinks
    申请人:Sawada Haruji
    公开号:US20050244426A1
    公开(公告)日:2005-11-03
    Secondary bile acid production inhibitors and cholesterol-lowering agents containing a yeast as the active ingredient.
    含有酵母作为活性成分的次级胆汁酸生产抑制剂和降低胆固醇药物。
  • Use of pregnane steroid derivatives for enhancing physical performance
    申请人:Marchewitz Eric
    公开号:US20060211667A1
    公开(公告)日:2006-09-21
    A method of increasing lean body mass in humans comprises administering a pregnane steroid derivative or a physiologically acceptable salt or ester thereof of the general formula: wherein R1=H and R2=H, or R1 and R2 combined form a single bond; R3 is one of OH and O; R5 is one of an α-hydrogen and a β-hydrogen; R6 is one of α-methyl and H; R7 is one of α-methyl and H; R17 is one of H and OH; and R20 is one of OH and O.
  • METHODS, COMPOSITIONS, AND KITS FOR THE TREATMENT OF CANCER
    申请人:Haggerty Timothy J.
    公开号:US20140335050A1
    公开(公告)日:2014-11-13
    The invention features methods, compositions, and kits for the administration of an HSP90 inhibitor, OBAA, flunarizine, aphidicolin, damnacanthal, dantrolene, or an analog thereof, alone, or in combination with, e.g., a TAA, an antigen-binding scaffold (e.g., an antibody, a soluble T cell receptor, or a chimeric receptor) specific for a TAA, a cell (e.g., a white blood cell that targets a cancer cell), and/or an IFN-β receptor agonist or an IFN-γ receptor agonist, for the treatment of cancer.
  • US5846954A
    申请人:——
    公开号:US5846954A
    公开(公告)日:1998-12-08
  • US7101544B1
    申请人:——
    公开号:US7101544B1
    公开(公告)日:2006-09-05
查看更多